Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties

Published 2017 View Full Article

Authors

Keywords

multiple myeloma, dendritic cells, lenalidomide, mesenchymal stromal cells, immunomodulation

Journal

Oncotarget

Volume 8, Issue 32, Pages -

Publisher

Impact Journals, LLC

Online

2017-05-23

DOI

10.18632/oncotarget.18085

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now